Nephroprotective role of dipyridamole in diabetic nephropathy: Effect on inflammation and apoptosis

Life Sciences

Volumn 143, Issue , 2015, Pages 8-17

  Elsherbiny, Nehal M ^a   Al Gayyar, Mohammed M H ^a,b   Abd El Galil, Khaled H ^c  

^a MANSOURA UNIVERSITY   (Egypt)

^b UNIVERSITY OF TABUK   (Saudi Arabia)

^c University of Mansoura   (Egypt)

Author keywords

Caspase 3 8 9; Diabetic nephropathy; Dipyridamole; ICAM 1; IL 1 10 18; JNK; TNF

Indexed keywords

9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE; CASPASE 3; CASPASE 8; CASPASE 9; CELL ADHESION MOLECULE; DIPYRIDAMOLE; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; FOCAL GLOMERULOSCLEROSIS; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KIDNEY; MESANGIUM CELL; NONHUMAN; NUCLEOSIDE TRANSPORT; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; CELL CULTURE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS; MALE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ADENOSINE; ANIMALS; APOPTOSIS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DIPYRIDAMOLE; HUMANS; INFLAMMATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 84947436555     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.10.026     Document Type: Article

References (50)

1. A. Avogaro, and G. Schernthaner Achieving glycemic control in patients with type 2 diabetes and renal impairment Acta Diabetol. 50 3 2013 283 291
2. R. Rabkin Diabetic nephropathy Clin. Cornerstone 5 2 2003 1 11
3. K.L. Ma, Y. Zhang, J. Liu, Y. Wu, Z.B. Hu, X.Z. Ruan, and B.C. Liu Establishment of an inflamed animal model of diabetic nephropathy Int. J. Biol. Sci. 10 2 2014 149 159
4. G. Hasko, and B. Cronstein Regulation of inflammation by adenosine Front. Immunol. 485 2013
5. P.B. Ernst, J.C. Garrison, and L.F. Thompson Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology J. Immunol. 2010 1993-1998 185(4)
6. G.I. Liou, J.A. Auchampach, C.J. Hillard, G. Zhu, B. Yousufzai, S. Mian, S. Khan, and Y. Khalifa Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor Invest. Ophthalmol. Vis. Sci. 49 12 2008 5526 5531
7. E. Narimatsu, T. Niiya, M. Kawamata, and A. Namiki Adenosine and adenosine uptake inhibitors potentiate the neuromuscular blocking action of rocuronium mediated by adenosine A(1) receptors in isolated rat diaphragms Acta Anaesthesiol. Scand. 52 10 2008 1415 1422
8. H.K. Eltzschig, P. Abdulla, E. Hoffman, K.E. Hamilton, D. Daniels, C. Schonfeld, M. Loffler, G. Reyes, M. Duszenko, J. Karhausen, A. Robinson, K.A. Westerman, I.R. Coe, and S.P. Colgan HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia J. Exp. Med. 202 11 2005 1493 1505
9. T. Noji, M. Takayama, M. Mizutani, Y. Okamura, H. Takai, A. Karasawa, and H. Kusaka KF24345, an adenosine uptake inhibitor, suppresses lipopolysaccharide-induced tumor necrosis factor-alpha production and leukopenia via endogenous adenosine in mice J. Pharmacol. Exp. Ther. 300 1 2002 200 205
10. T. Noji, A. Karasawa, and H. Kusaka Adenosine uptake inhibitors Eur. J. Pharmacol. 495 1 2004 1 16
11. P. Balakumar, R. Varatharajan, Y.H. Nyo, R. Renushia, D. Raaginey, A.N. Oh, S.S. Akhtar, M. Rupeshkumar, K. Sundram, and S.A. Dhanaraj Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development ofnephropathy in diabetic rats Pharmacol. Res. 90 2014 36 47
12. I.L. da Silva Torres, C.D. Bonan, L. Crema, M. De Leon Nunes, A.M. Battastini, J.J. Sarkis, C. Dalmaz, and M.B. Ferreira Effect of drugs active at adenosine receptors upon chronic stress-induced hyperalgesia in rats Eur. J. Pharmacol. 481 2-3 2003 197 201
13. M. Imaizumi, S. Miyazaki, and K. Onodera Effects of a non-xanthine adenosine antagonist, CGS 15943, and a phosphodiesterase inhibitor, Ro 20-1724, in a light/dark test in mice Methods Find. Exp. Clin. Pharmacol. 16 10 1994 717 721
14. N.M. Elsherbiny, K.H. Abd El Galil, M.M. Gabr, M.M. Al-Gayyar, L.A. Eissa, and M.M. El-Shishtawy Reno-protective effect of NECA in diabetic nephropathy: implication of IL-18 and ICAM-1 Eur. Cytokine Netw. 23 3 2012 78 86
15. K. Satoh Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method Clin. Chim. Acta 90 1 1978 37 43
16. L.R. DeChatelet, C.E. McCall, L.C. McPhail, and R.B. Johnston Jr. Superoxide dismutase activity in leukocytes J. Clin. Invest. 53 4 1974 1197 1201
17. M.M. Darweish, A. Abbas, M.A. Ebrahim, and M.M. Al-Gayyar Chemopreventive and hepatoprotective effects of epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway J Pharm Pharmacol 66 7 2014 1032 1045
18. A. Mima Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets J. Diabetes Res. 2013248563 2013
19. E. Tak, D. Ridyard, J.H. Kim, M. Zimmerman, T. Werner, X.X. Wang, U. Shabeka, S.W. Seo, U. Christians, J. Klawitter, R. Moldovan, G. Garcia, M. Levi, V. Haase, K. Ravid, H.K. Eltzschig, and A. Grenz CD73-dependent generation of adenosine and endothelial Adora2b signaling attenuate diabetic nephropathy J. Am. Soc. Nephrol. 25 3 2014 547 563
20. B.P. Ramakers, N.P. Riksen, T.H. Stal, S. Heemskerk, P. van den Broek, W.H. Peters, J.G. van der Hoeven, P. Smits, and P. Pickkers Dipyridamole augments the antiinflammatory response during human endotoxemia Crit. Care 15 6 2011 R289
21. N.M. Elsherbiny, and M.M. Al-Gayyar Adenosine receptors: new therapeutic targets for inflammation in diabetic nephropathy Inflamm. Allergy Drug Targets 12 3 2013 153 161
22. A.K. Sharma, D. Khanna, and P. Balakumar Low-dose dipyridamole treatment partially prevents diabetes mellitus-induced vascular endothelial and renal abnormalities in rats Int. J. Cardiol. 172 2 2014 530 532
23. L.L. Howell, and L.D. Byrd Effects of CGS 15943, a nonxanthine adenosine antagonist, on behavior in the squirrel monkey J. Pharmacol. Exp. Ther. 267 1 1993 432 439
24. M.K. Arora, and U.K. Singh Oxidative stress: meeting multiple targets in pathogenesis of diabetic nephropathy Curr. Drug Targets 15 5 2014 531 538
25. F. Vargas, C. Rivas, Y. Diaz, N. Contreras, A. Silva, L.E. Ojeda, M. Velasquez, and G. Fraile Antioxidant properties of dipyridamole as assessed by chemiluminescence Pharmazie 58 11 2003 817 823
26. S. Del Ry, M.A. Morales, M.C. Scali, A. Tafi, C. Giustarini, F. Posteraro, V. Ambrosini, M. Agrusta, E. Picano, and R. Sicari Effect of concomitant oral chronic dipyridamole therapy on inflammatory cytokines in heart failure patients Clin. Lab. 59 7-8 2013 843 849
27. A. Fornoni, A. Ijaz, T. Tejada, and O. Lenz Role of inflammation in diabetic nephropathy Curr. Diabetes Rev. 4 1 2008 10 17
28. T. Fujita, N. Ogihara, Y. Kamura, A. Satomura, Y. Fuke, C. Shimizu, Y. Wada, and K. Matsumoto Interleukin-18 contributes more closely to the progression of diabetic nephropathy than other diabetic complications Acta Diabetol. 49 2 2012 111 117
29. M. Soliman Nucleoside transport inhibitor, dipyridamole, induced myocardial protection following hemorrhagic shock in ex vivo perfused rat hearts J. Saudi Heart Assoc. 23 2 2011 75 80
30. J. Linden Role of adenosine in response to vascular inflammation Arterioscler. Thromb. Vasc. Biol. 32 4 2012 843 844
31. S. Save, C. Mohlin, R. Vumma, and K. Persson Activation of adenosine A2A receptors inhibits neutrophil transuroepithelial migration Infect. Immun. 79 8 2011 3431 3437
32. S. Poturoglu, S. Kaymakoglu, N. Gurel Polat, D. Ibrisim, E. Ahishali, F. Akyuz, S. Badur, K. Demir, and Z. Mungan A new agent for tumour necrosis factor-alpha inhibition: in vitro effects of dipyridamole in Crohn's disease Scand. J. Clin. Lab. Invest. 69 6 2009 696 702
33. M. Chello, P. Mastroroberto, E. Malta, F. Cirillo, and V. Celi Inhibition by dipyridamole of neutrophil adhesion to vascular endothelium during coronary bypass surgery Ann. Thorac. Surg. 67 5 1999 1277 1282
34. M. Girndt, H. Kohler, E. Schiedhelm-Weick, J.F. Schlaak, K.H. Meyer zum Buschenfelde, and B. Fleischer Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients Kidney Int. 47 2 1995 559 565
35. F.A. Wagener, D. Dekker, J.H. Berden, A. Scharstuhl, and J. van der Vlag The role of reactive oxygen species in apoptosis of the diabetic kidney Apoptosis 14 12 2009 1451 1458
36. K. Susztak, A.C. Raff, M. Schiffer, and E.P. Bottinger Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy Diabetes 55 1 2006 225 233
37. B.P. Kang, S. Frencher, V. Reddy, A. Kessler, A. Malhotra, and L.G. Meggs High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism Am. J. Physiol. Renal. Physiol. 284 3 2003 F455 F466
38. X. Zhang, Y. Zhao, Q. Chu, Z.Y. Wang, H. Li, and Z.H. Chi Zinc modulates high glucose-induced apoptosis by suppressing oxidative stress in renal tubular epithelial cells Biol. Trace Elem. Res. 158 2 2014 259 267
39. A. Kuhad, and K. Chopra Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway Life Sci. 84 9-10 2009 296 301
40. H.B. Lee, M.R. Yu, Y. Yang, Z. Jiang, and H. Ha Reactive oxygen species-regulated signaling pathways in diabetic nephropathy J. Am. Soc. Nephrol. 14 8 Suppl 3 2003 S241 S245
41. C.H. Yeh, C.K. Chang, M.F. Cheng, H.J. Lin, and J.T. Cheng The antioxidative effect of bone morphogenetic protein-7 against high glucose-induced oxidative stress in mesangial cells Biochem. Biophys. Res. Commun. 382 2 2009 292 297
42. Y. Pan, Y. Wang, L. Cai, Y. Cai, J. Hu, C. Yu, J. Li, Z. Feng, S. Yang, X. Li, and G. Liang Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats Br. J. Pharmacol. 166 3 2012 1169 1182
43. P.B. Pal, K. Sinha, and P.C. Sil Mangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, TNFalpha related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic rats PLoS One 9 9 2014 e107220
44. J. Gao, F. Wang, W. Wang, Z. Su, C. Guo, and S. Cao Emodin suppresses hyperglycemia-induced proliferation and fibronectin expression in mesangial cells via inhibiting cFLIP PLoS One 9 4 2014 e93588
45. D. Yang, T. Yaguchi, T. Nakano, and T. Nishizaki Adenosine-induced caspase-3 activation by tuning Bcl-XL/DIABLO/IAP expression in HuH-7 human hepatoma cells Cell Biol. Toxicol. 26 4 2010 319 330
46. D. Yang, T. Yaguchi, H. Yamamoto, and T. Nishizaki Intracellularly transported adenosine induces apoptosis in HuH-7 human hepatoma cells by downregulating c-FLIP expression causing caspase-3/-8 activation Biochem. Pharmacol. 2007 1665-1675 73(10)
47. L.F. Wu, G.P. Li, J.L. Feng, and Z.J. Pu Molecular mechanisms of adenosine-induced apoptosis in human HepG2 cells Acta Pharmacol. Sin. 27 4 2006 477 484
48. J. Wu, C. Mei, H. Vlassara, G.E. Striker, and F. Zheng Oxidative stress-induced JNK activation contributes to proinflammatory phenotype of aging diabetic mesangial cells Am. J. Physiol. Renal. Physiol. 297 6 2009 F1622 F1631
49. L. Zhang, S. Pang, B. Deng, L. Qian, J. Chen, J. Zou, J. Zheng, L. Yang, C. Zhang, X. Chen, Z. Liu, and Y. Le High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-kappaB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol Int. J. Biochem. Cell Biol. 44 4 2012 629 638
50. D.W. Cheng, Y. Jiang, A. Shalev, R. Kowluru, E.D. Crook, and L.P. Singh An analysis of high glucose and glucosamine-induced gene expression and oxidative stress in renal mesangial cells Arch. Physiol. Biochem. 112 4-5 2006 189 218